
- RenaissanceRe reported net investment income of $428.8 million for the fourth quarter.
- This income represents a 14% increase compared to the previous year.
- The reported net investment income exceeded the analysts’ estimate of $415.4 million.
- Operating earnings per share (EPS) for the quarter were $8.06.
- The operating EPS decreased compared to $11.77 from the previous year.
- The company’s stock has received mixed recommendations from analysts, with 6 buy ratings, 6 hold ratings, and 2 sell ratings.
A look at Renaissancere Holdings Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 5 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Looking at the Smartkarma Smart Scores for Renaissancere Holdings, the company seems to have a promising long-term outlook ahead. With high scores in Growth and Resilience, indicating strong potential for expansion and ability to withstand market challenges, Renaissancere Holdings appears to be well-positioned for future success. Additionally, a moderate score in Value suggests that the company may offer fair value for investors looking for stable returns. Although the Dividend and Momentum scores are not as high, the overall positive outlook driven by Growth and Resilience bodes well for the company’s future performance.
Summary: RenaissanceRe Holdings Ltd. is a global reinsurance and insurance provider, specializing in catastrophe reinsurance, specialty reinsurance, and individual risk business. With a strong focus on growth and resilience, Renaissancere Holdings is poised to navigate through market uncertainties and drive sustained expansion in the insurance industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars